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Background: The latest meta-analysis demonstrated that acupuncture improves pregnancy rates among women
undergoing in vitro fertilization-embryo transfer (IVF-ET), and surface acupoint stimulation, such as transcutaneous
electrical acupoint stimulation (TEAS), may have the same or better potential.
Methods/Design: To explore the effect of TEAS on the clinical pregnancy rate (CPR) and live birth rate (LBR)
compared with real acupuncture and controls in women undergoing IVF, a multicenter, randomized controlled trial
will be conducted. The inclusion criteria are the following: infertile women <40 years of age undergoing a fresh IVF
or intracytoplasmic sperm injection cycle, and the study will be restricted to women with the potential for a lower
success rate as defined by two or more previous unsuccessful ETs (fresh or frozen). Those who have severe illnesses
possibly precluding IVF or pregnancy, have FSH levels greater than 20 IU/L, received donor eggs, had been
previously randomized for this study or had undergone acupuncture (in any modality) as infertility treatment will
be excluded. The subjects will be randomly assigned to the TEAS group (IVF + TEAS), the electro-acupuncture
(EA) group (IVF + EA), or the control group (only IVF). A total sample size of 2,220 women is required to detect
differences in CPR among the three groups. TEAS or EA treatments will start once every two or three days from day
3 of menstruation in the ovarian stimulation cycle until the day of ET. The parameters of TEAS or EA will be the
following: a frequency of 2/100 Hz, a moderate electrical current of 3 to 5 mA for TEAS and 0.8 to 1.0 mA for EA.
The primary outcome is CPR. Secondary outcomes are LBR, the number of oocytes aspirated and the total
gonadotropin dose used in the stimulation cycle.
Discussion: This study will provide significant evidence for using a new method (TEAS) in IVF.
Trial registration: ClinicalTrials.govID: NCT01608048 (05/24/2012).
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In vitro fertilization-embryo transfer (IVF-ET) is the most
successful infertility treatment, and for many people, this
treatment represents the last possibility for pregnancy.
However, the average IVF success rate per cycle using
fresh, nondonor oocytes is still not satisfactory [1]. The
majority of IVF cycles do not result in pregnancy. Al-
though techniques such as controlled ovarian hyperstimu-
lation (COH), in vitro fertilization, and embryo culture
and transfer have greatly improved, certain patients are
not successfully treated, even after several ETs.
Concurrently, the latent safety problems associated with
using large doses of ovulation stimulants to obtain more
eggs for IVF cannot be ignored [2]. Furthermore, IVF is an
expensive procedure. Repeated cycles place a heavy finan-
cial burden on patients and their families. Therefore, it is
important to maximize the efficiency of the procedure.
Many patients have turned to complementary and alterna-
tive medical (CAM) treatments to increase the success
rate of IVF. Among these CAM treatments, acupuncture
is a frequently used adjunctive therapy.
Since the first report by Stener-Victorin et al. in 1999
[3] suggesting that acupuncture can increase the IVF
clinical pregnancy rate (CPR), application of acupunc-
ture to IVF has attracted considerable interest from the
international community. In recent years, there have
been a total of 23 randomized controlled trials (RCTs)
evaluating acupuncture in IVF [3-25]. The latest com-
prehensive meta-analysis [26] of these trials demon-
strated the following:
1. Acupuncture improved CPR among women
undergoing IVF (Acu. versus Con.:39.5% versus
37.2%, OR = 1.21, 95% CI = (1.00, 1.46)).
2. The difference was more distinct when the types of
controls and/or different acupuncture times were
examined in a sensitivity analysis. Acupuncture at
approximately the same time as COH is more
suitable than when performed only concurrently
with oocyte aspiration (OA) or embryo transfer (ET)
(COH: Acu. versus Con., 31.5% versus 21.2%, OR =
1.75, 95% CI = (1.13, 2.71)).
3. Increasing stimulation intensity at the acupoint
surface (as occurred in the Streitberger group), such
as transcutaneous electro-stimulation, might induce
the same or better therapeutic effects.
The results indicated that more positive effects from
acupuncture during IVF can be expected if treatment
times are appropriate, the treatment course is enough
(at least four sessions), the means of intervention is im-
proved, and syndrome differentiation and treatment ac-
cording to individual characteristics is emphasized in
future programs.Transcutaneous electrical acupoint stimulation (TEAS)
is a combination of transcutaneous electrical stimulation
from the West and acupoints from traditional Chinese
medicine, which is a method of inputting low frequency-
pulse current into the body via the skin to treat diseases
such as pain. Real acupuncture is often accompanied by
some degree of discomfort or pain, and a portion of
patients are afraid of acupuncture. However, this short-
coming of real acupuncture can be avoided by non-
invasive stimulation (TEAS), and patients may find it
more acceptable, both physically and mentally. There-
fore, TEAS may have a more positive therapeutic effect.
Zhang R demonstrated the positive effects of TEAS in
women undergoing IVF [26], but there were no compar-
isons between TEAS and electro-acupuncture (EA).
Thus, the primary purpose of this study is to explore
whether there are any differences between EA and TEAS
in increasing pregnancy rates in women undergoing IVF
compared with conventional IVF.
Methods/Design
This study is designed as a multicenter, randomized,
parallel-controlled, assessor- and statistician-blinded trial.
Participants will be included from the following five
hospitals: Affiliated Tongji Hospital, Union Hospital of
Huazhong University of Science and Technology, Wuhan
General Hospital of Guangzhou Military Command, Hubei
Maternity and Child Care Hospital, and Renmin Hospital
of Wuhan University. Each research center must be in strict
accordance with the inclusion and exclusion criteria.
The study will be conducted in the following sequence:
patients will be enrolled after screening via the eligibility
criteria, they will be randomized, they will undergo
an approximate two-week treatment period, they will
undergo a 40-week follow-up period, and assessment
will follow. The research protocol has been approved by
the Clinical Trial Ethics Committee of Tongji Medical
College, Huazhong University of Science and Technol-
ogy (approval number: (2012) (110)-1) and registered
on the ClinicalTrials.gov Protocol Registration System
(https://register.clinicaltrials.gov, ClinicalTrials.govID: NCT
01608048). Written informed consent will be obtained from
each participant. Patients will be recruited to join the study
only once and will not receive any monetary compensation
for study participation.
Eligibility criteria
Women presenting to the reproductive medicine center of
the involved hospitals will be screened for fitness to
undergo IVF. All of the women with an indication for IVF,
such as tubal infertility, severe male factor infertility,
severe endometriosis, unexplained infertility, immune
infertility, and anovulatory infertility, will be informed
of the study.
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women <40 years of age undergoing a fresh IVF or intra-
cytoplasmic sperm injection (ICSI) cycle; (2) who have a
potentially lower success rate, which is defined as two or
more previous unsuccessful ETs (fresh or frozen); (3)
who are willing to sign an informed consent form indi-
cating that they are aware of the investigational nature
of this study, which is in keeping with the institutional
policies; and (4) who are willing to return to the study
site for visits. The inclusion criteria were necessary be-
cause women who have experienced several unsuccessful
OAs or ETs may easily accept randomization into this
study, and adding TEAS or EA may significantly im-
prove their clinical outcomes.
The exclusion criteria are the following: (1) have major
medical illnesses (such as stage III heart disease, severe
hypertension, uncontrolled diabetes mellitus, positive
HIV status, severe bleeding dyscrasias, etcetera) possibly
precluding IVF or pregnancy; (2) have FSH levels greater
than 20 IU/L; (3) have received donor eggs; (4) have cu-
taneous lesions within the acupoint area; and (5) had
previously participated in this study or previously under-
gone acupuncture (in whatever modality) as infertility
treatment.
The withdrawal criteria are the following: (1) a patient
is deemed unfit for the inclusion criteria; (2) early dis-
continuation for any reason (for example, consent with-
drawal, adverse events, and treatment failure); (3) the
patient does not strictly abide by the intervention proto-
col or uses other methods beyond the project that may
affect pregnancy outcome; and (4) complete data missing
for primary outcomes.
Patients have the right to decline participation in the
study, and they may withdraw their consent at any time.
Their consent or refusal to consent will not affect their
expected IVF intervention.
Sample size
Sample size calculation is based on the increased range
of CPR from acupuncture as described in previous stud-
ies (13% to 18% based on the following studies: Stener-
Victorin, 17.6% [3]; Paulus, 16.2% [4]; Westergaard, 16%
[7]; Dieterle, 18% [8]; and Sator-Katzenschlager, 13.5%
[25]). Smith CA chose a conservative 7% estimate based
on their previous study [27]. The increased range of clin-
ical effects from TEAS compared with the control group
was 13.4% to 20.7% [28]. Therefore, we estimated a 7%
increase for the EA group and a 15% increase for the
TEAS group compared with the control group. The pos-
sible proportion of women with a clinical pregnancy for
women with two or more cycle failures in the control
group was 20% [27]. To detect differences using a pair-
wise comparison method, the sample size should be
1,850 according to optimum allocation (700 for theTEAS group, 700 for the EA group, and 450 for the con-
trol group) using the Shieh-O'Brien approximation
method assuming that alpha (two-sided) is 0.05, the
overall power is 0.90, the power between the TEAS and
EA groups is 0.80, and the power between the EA and
control group is also 0.80. A total sample size of 2,220
women (840 for the TEAS group, 840 for the EA group,
and 540 for the control group) is required allowing for a
20% loss due to canceled cycles or no ET.
Recruitment strategies and enrollment
A large number of infertile patients are currently seeking
treatments at Chinese hospitals. Patients will be re-
cruited mainly through advertisements placed via local
media (television and newspaper) and recruitment post-
ers in the reproductive center of the involved hospitals.
Interested patients will be screened by specific re-
searchers who are very familiar with the study inclusion
and exclusion criteria. The participants will be clearly
and comprehensively told about the trial in which they
will be participating such as the interests they will ob-
tain, potential risks, trial group settings, and possible in-
terventions they will receive. Baseline characteristics
such as age, infertility type and duration, IVF indication
and history, history of smoking or drinking, history of
exposure to radiotherapy or chemotherapy, history of
pelvic inflammatory disease (PID) or endometriosis, and
history of previous pelvic surgeries will be noted. Pa-
tients who are willing to participate and meet the eligi-
bility criteria will be introduced to the acupuncturist at
the hospitals.
Randomization and blinding
Included patients will be randomly divided into three
groups: the TEAS group (conventional IVF + TEAS), the
EA group (conventional IVF + EA), and the control
group (only conventional IVF).
Fundamental characteristics of randomization include
the inability of researchers to predict a patient’s assign-
ment and no assignment changes after randomization.
The randomization sequence will be generated by a com-
puterized random number generator using the simple-
randomization method (Excel, Microsoft Office 2007). A
‘patient’ database, which lists basic information such as
patient name and contact details and a ‘randomization’
database, which contains data on patients who were regis-
tered in the trial, along with their allocations, will be
generated. The ‘patients’ database is accessible to any
researcher, whereas the ‘randomization’ database is
password-protected; thus, it will be accessible only by the
principal investigator and a nominated computer techni-
cian. Immediately before intervention, the acupuncturists
will access the ‘patients’ database, type in the patient’s
name and details, and hit an icon to randomize the
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searcher to confirm that the patient is eligible. After
the ‘okay’ button is pressed, patient information is auto
matically sent to the randomization database, where
randomization takes place [29]. Grouping information
will subsequently be sent to the acupuncturists for
TEAS or EA treatments.
The assessor will assess the treatment outcome. The
assessor will not be the acupuncture practitioner and
will be blinded to the allocation results until the end of
the study. The statistician will also be blinded to the
concrete allocation until after the statistical analysis. The
procedure will be performed with blinded staff as much
as possible; however, the patients and the acupuncturists
will not be blinded because the control group did not
obtain sham TEAS or sham acupuncture.
In vitro fertilization procedure
All included patients then will start IVF cycles using the
long GnRH agonist protocol beginning on day 21 of the
menstrual cycle until human chorionic gonadotropin
(hCG) injection. Controlled ovarian stimulation will be
performed from day 2 or 3 of the subsequent cycle with
urinary or recombinant gonadotropin, the dose of which
is individualized based on the anticipated response. The
ovarian response will be monitored with ultrasound, and
E2 levels will be estimated. The hCG trigger will be
given on the day when three or more developing follicles
18 mm in size or larger are observed on transvaginal
sonography. The total gonadotropin dose used to
achieve the response as well as E2 levels on the day of
hCG administration will be noted. Oocytes will be aspi-
rated 36 h after hCG administration under transvaginal
ultrasound guidance by experienced doctors. The ovar-
ian response is defined as the number of oocytes ob-
tained during the oocyte aspiration procedure. ET will
be performed 72 h after oocyte aspiration.
Acupuncture intervention(s)
All of the participants will undergo traditional Chinese
medicine (TCM) diagnosis. TCM diagnosis in the great
majority of infertile patients is kidney and spleen defi-
ciency, liver qi stagnation, dampness, or blood stasis, or
multiple diagnoses. Therefore, acupoints for the TEAS
and EA groups are chosen according to the TCM dia-
lectical treatment principle and our former experimental
results [30]. The main acupoints are bilateral Zusanli
(ST36), Sanyinjiao (SP6) and Taichong (LR3) (Figure 1).
ST36 is an important health care acupoint of the stom-
ach meridian, which can enhance spleen and stomach
function and help generate qi and blood. SP6 is the con-
fluent acupoint of foot three (kidney, spleen and liver)
yin meridians, which can supplement the three yins and
can regulate qi and blood. LR3 is the liver meridianyuan-source acupoint, which can assist SP6 to soothe
the liver and regulate qi and blood. Bilateral Taixi (KI3)
will be added for patients with kidney deficiency, Hegu
(LI4) will be added to assist Taichong (LR3) for patients
with liver qi stagnation, and Fenglong (ST40) is for patients
who have too much dampness in the body. Therefore, eight
acupoints will be used for treating each patient. The com-
bination of ST36, SP6 and LR3 can guarantee basic regula-
tion of qi and blood throughout the body. Subsequent
modification according to the syndrome differentiation
meets the demand of the highlighted syndrome.
The TEAS or EA groups will receive a conventional
IVF procedure with the addition of TEAS or EA at acu-
points. For the EA group, sterile, disposable needles
made in Shanghai (China) will be used to a depth of 5 to
20 mm in the selected acupoints after disinfection. The
needles will be 25 to 50 mm in length and 0.3 mm in
diameter. The qi sensation will be achieved by lifting
and thrusting movements combined with needle twirling
and rotation. Two homolateral acupuncture needles will
be connected to form a circuit containing a HANS-
100B stimulator (Nanjing Jisheng Company, China) for
30 min. The TEAS group will use skin electrodes placed
on acupoints instead of piercing the skin with needles.
The TEAS or EA parameters are as follows: alternating
2/100 Hz frequency wave, moderate 0.8 to 1.0 mA elec-
trical current for EA, and 3 to 5 mA for TEAS with a
30×30 mm skin electrode.
TEAS or EA treatments will start from day 3 of men-
struation in the ovarian stimulation cycle once every two
or three days, 30 min each for more than two weeks
until the day of ET. Women in the control group will re-
ceive only the conventional IVF procedure.
In total, two acupuncturists from each hospital with a
minimum of two years of clinical experience will partici-
pate in this process. Training in the treatment protocol,
study intent or treatment aspirations, treatment record-
ing, and an explanation of proposed future monitoring
will be provided to the acupuncturists.
Outcome measures
The primary outcome measure is clinical pregnancy (con-
firmed by ultrasound scan 5 to 6 weeks after ET demon-
strating at least one gestational sac with fetal heart activity).
Secondary outcome measures are live birth (defined as
the delivery of one or more living infants, >20 weeks
gestation or 400 g or more birth weight), number of oo-
cytes retrieval (OCR) and the total gonadotropin dose
used in the ovarian stimulation cycle. Ovarian responses
are defined according to three categories: poor response,
three or fewer OCR; average response, 4 to15 OCR;
hyper-response, more than 15 OCR.
Clinical data will be collected from the IVF center da-
tabases and from the patients by following up at 6 and
Figure 1 Acupoint locations.
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any adverse events will be collected from the practi-
tioner treatment notes.
Quality control
To guarantee the study quality, all of the researchers will
be required to attend all of the training classes and pass
the training test. They must master all of the details of
this trial before performing it. For instance, they must
master using the randomization method and filling in
the case report form (CRF). The acupuncturists should
also master finding the correct points and manipulating
the needles and electro-acupuncture apparatus. The as-
sessors should master how to collect and input data ac-
curately and completely.
During the trial, all of the details including all adverse
events such as broken needles, bleeding, hematomas,
fainting, serious pain, and local infection will be recorded.
Serious adverse events will be immediately reported to the
principal investigator, and rescue procedures will be initi-
ated immediately.
To ensure trial quality, a clinical monitor designated
by the principal investigator will verify all of the process
details at regular intervals. Moreover, the monitor will
check the authenticity of the data.
Statistical analysis
Baseline subject characteristics are described by descrip-
tive analysis, and the balance among groups or subgroupswas assessed by analysis of variance or χ2-test. To assess
effects of TEAS and EA, the χ2-test will be applied to
compare frequencies between groups such as the CPR and
LBR, and analysis of variance will be performed to com-
pare continuous parameters (gonadotropin dose for ex-
ample) between the groups (α = 0.05). All of the analyses
will be based on both an intention-to-treat analysis (ITT,
with all randomized patients) and a treated-per-protocol
analysis (TPP, with all randomized patients minus with-
drawals). Missing patient data for those that dropped
out of the study will be analyzed using the last observa-
tion carried forward method. Patients with complete
data missing for primary outcomes will be considered
as a negative ITT pregnancy result and eliminated in
the TPP analysis.
Discussion
IVF is an option for many infertile women, their fam-
ilies and the public, but because of the relatively low
success rate, high cost, and possible latent safety prob-
lems, new therapies that can improve pregnancy out-
comes are highly desirable.
Acupuncture is a frequently used adjunctive therapy
for many diseases. The application of acupuncture to
IVF has attracted more doctors and patients. Based on
the published data, this study will provide significant evi-
dence for using a new method (TEAS) with IVF to im-
prove reproductive outcomes. Although one trial [28]
has already reported that TEAS significantly improved
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ment courses or times can be further optimized. There-
fore, with appropriate intervention times (from the time
of COH to the day of ET), enough treatment courses
(six or seven sessions), syndrome differentiation and
treatment according to individual characteristics, TEAS
may produce a pleasantly surprising result.
In this protocol, we will select the intervention time
from COH to ET, from day 3 of the ovarian stimulation
cycle to the day of ET to obtain better results. Reasons for
this are as follows: 1) the latest meta-analysis demon-
strated that acupuncture at approximately the time of
COH is the most suitable; 2) according to the studies of
Paulus 2002 [4], Westergaard 2006 [7] and Zhang 2011
[28], acupuncture on the day of ET can significantly im-
prove the reproductive outcome of IVF/ICSI; and 3)
correcting the state of infertility caused by long-term
insufficiency or imbalance requires enough treatment
courses.
The control group was based on the fact that any sur-
face stimulation at acupoints, such as acupressure, can
cause a physiological reaction or effect [16]. Thus, the
control group will not receive any sham TEAS or acu-
puncture, and they are included mainly as a control
group for providing a baseline pregnancy rate. To avoid
the psychological placebo effect, every participant will be
informed that the TEAS or EA treatments are safe but
that procedure effectiveness is unknown.
TEAS or EA frequency is an important issue for con-
sideration. The alternating wave is the most frequently
used wave in clinical acupuncture. Therefore, in this
trial, we will determine an alternating wave with a rela-
tively broad frequency range (2/100 Hz) for the TEAS or
EA intervention. The electrical current is moderate at
0.8 to 1.0 mA for EA and 3 to 5 mA for TEAS based on
patient comfort and will not reach the sustain threshold
but can obviously be perceived by the patients.
Trial status
This trial is currently preparing to recruit participants.
The enrollment will begin on 1 May 2014 and is ex-
pected to be completed before 1 May 2016.
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